Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Journal articles
, 2019, 'Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib', Rmd Open, 5, http://dx.doi.org/10.1136/rmdopen-2018-000742
, 2018, 'Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population', Rheumatology and Therapy, 5, pp. 383 - 401, http://dx.doi.org/10.1007/s40744-018-0118-2
, 2018, 'Effectiveness of biologics in Australian patients with rheumatoid arthritis: a large observational study: REAL', Internal Medicine Journal, 48, pp. 1185 - 1192, http://dx.doi.org/10.1111/imj.14028
, 2018, 'A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population', International Journal of Rheumatic Diseases, 21, pp. 1581 - 1590, http://dx.doi.org/10.1111/1756-185X.13243
, 2018, 'A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis – the HUMOR trial', Osteoarthritis and Cartilage, 26, pp. 880 - 887, http://dx.doi.org/10.1016/j.joca.2018.02.899
, 2018, 'Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: Results of the randomized, placebocontrolled PALACE 4 trial', Rheumatology (United Kingdom), 57, pp. 1253 - 1263, http://dx.doi.org/10.1093/rheumatology/key032
, 2018, 'Evaluation of the effect of baseline MRI sacroiliitis and c reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: A post hoc analysis of the EMBARK study', Annals of the Rheumatic Diseases, 77, pp. 1090 - 1093, http://dx.doi.org/10.1136/annrheumdis-2017-211313
, 2018, 'Turbulent shear layers in confining channels', Journal of Turbulence, 19, pp. 431 - 445, http://dx.doi.org/10.1080/14685248.2018.1459630
, 2018, 'Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors', Clinical Rheumatology, 37, pp. 1617 - 1623, http://dx.doi.org/10.1007/s10067-018-4105-3
, 2018, '226 Summary of baricitinib effect on patient-reported outcomes (PROs) in methotrexate-inadequate responder patient population', Rheumatology, 57, pp. key075.450, http://dx.doi.org/10.1093/rheumatology/key075.450
, 2018, 'Magnetic resonance imaging (MRI) of feet demonstrates subclinical inflammatory joint disease in cutaneous psoriasis patients without clinical arthritis', Clinical Rheumatology, 37, pp. 383 - 388, http://dx.doi.org/10.1007/s10067-017-3895-z
, 2018, 'AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid Arthritis', International Journal of Rheumatology, 2018, pp. 8721753, http://dx.doi.org/10.1155/2018/8721753
, 2018, 'Psoriatic arthritis treatment regimens, therapy duration and reasons for cessation in the biologics era: A multi-centre Australian study', International Journal of Rheumatic Diseases, 21, pp. 510 - 516, http://dx.doi.org/10.1111/1756-185X.13127
, 2018, 'Optimal control of diffuser shapes for non-uniform flow', Journal of Engineering Mathematics, 113, pp. 65 - 92, http://dx.doi.org/10.1007/s10665-018-9974-6
, 2017, 'Vertebroplasty for acute painful osteoporotic fracture', Medical Journal of Australia, 207, pp. 279 - 281.e1, http://dx.doi.org/10.5694/mja16.01423
, 2017, 'Criticisms of the VAPOUR trial in a recent commentary are unsubstantiated and incorrect', Evidence Based Medicine, 22, pp. 116 - 117, http://dx.doi.org/10.1136/ebmed-2017-110737
, 2017, 'Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study', International Journal of Rheumatic Diseases, 20, pp. 460 - 468, http://dx.doi.org/10.1111/1756-185X.13036
, 2017, 'Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)', Annals of the Rheumatic Diseases, 76, pp. 694 - 700, http://dx.doi.org/10.1136/annrheumdis-2016-209821
, 2017, 'Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand', Journal of Medical Imaging and Radiation Oncology, 61, pp. 58 - 69, http://dx.doi.org/10.1111/1754-9485.12573
, 2017, 'The CEDAR Study: A longitudinal study of the clinical effects of conventional DMARDs and biologic DMARDs in Australian rheumatology practice', International Journal of Rheumatology, 2017, pp. 1201450, http://dx.doi.org/10.1155/2017/1201450
, 2017, 'A randomised double-blind placebo-controlled crossover trial of humira (adalimumab) for erosive hand osteoarthritis: the humor trial', Osteoarthritis and Cartilage, 25, pp. s9, http://dx.doi.org/10.1016/j.joca.2017.02.032
, 2016, 'Apremilast monotherapy as the first systemic treatment in DMARD-naive patients with active psoriatic arthritis: 3-year treatment results', Revue Du Rhumatisme Edition Francaise, 83, pp. A249, http://dx.doi.org/10.1016/S1169-8330(16)30589-0
, 2016, 'Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (104-week) improvement in fatigue in patients with psoriatic arthritis: Pooled results from 3 Phase III, randomized, controlled trials', Revue Du Rhumatisme Edition Francaise, 83, pp. A248 - A249, http://dx.doi.org/10.1016/S1169-8330(16)30588-9
, 2016, 'Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: A phase III, randomised, controlled trial (PALACE 3)', Annals of the Rheumatic Diseases, 75, pp. 1065 - 1073, http://dx.doi.org/10.1136/annrheumdis-2015-207963
, 2016, '194 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (104 Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III Randomized Controlled Trials', Rheumatology, 55, pp. i140 - i141, http://dx.doi.org/10.1093/rheumatology/kew145.005
, 2016, 'Evaluation of magnetic resonance imaging responsiveness in active psoriatic arthritis at multiple timepoints during the first 12 weeks of antitumor necrosis factor therapy', Journal of Rheumatology, 43, pp. 75 - 80, http://dx.doi.org/10.3899/jrheum.150347
, 2016, 'AB0344 A Retrospective Non-Interventional Study on The Use of Biologics in The Treatment of Australian Patients with Rheumatoid Arthritis-The Real Study', Annals of the Rheumatic Diseases, 75, pp. 1019 - 1020, http://dx.doi.org/10.1136/annrheumdis-2016-eular.4470
, 2016, 'AB0368 AC-Cute: An Open-Label Study To Evaluate Non-Progression of Structural Joint Damage in Patients with Moderate To Severe Active Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab', Annals of the Rheumatic Diseases, 75, pp. 1029 - 1030, http://dx.doi.org/10.1136/annrheumdis-2016-eular.3780
, 2016, 'FRI0521 Reliability of An Omeract Rheumatoid Arthritis Tenosynovitis Scoring System for Wrist and Hand', Annals of the Rheumatic Diseases, 75, pp. 627 - 628, http://dx.doi.org/10.1136/annrheumdis-2016-eular.1445
, 2016, 'Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial', Lancet, 388, pp. 1408 - 1408, http://dx.doi.org/10.1016/S0140-6736(16)31341-1
, 2016, 'THU0422 Apremilast Monotherapy as The First Systemic Treatment in DMARD-Naïve Patients with Active Psoriatic Arthritis: 3-Year Treatment Results', Annals of the Rheumatic Diseases, 75, pp. 342, http://dx.doi.org/10.1136/annrheumdis-2016-eular.2405
, 2016, 'THU0432 Apremilast, An Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from 3 Phase III, Randomized, Controlled Trials', Annals of the Rheumatic Diseases, 75, pp. 346, http://dx.doi.org/10.1136/annrheumdis-2016-eular.1487
, 2016, 'THU0436 A Retrospective Non-Interventional Multi-Centre Study Evaluating Treatment Regimens Used in Psoriatic Arthritis Patients in Australia- The PSA Real Study', Annals of the Rheumatic Diseases, 75, pp. 348, http://dx.doi.org/10.1136/annrheumdis-2016-eular.2099
, 2016, 'Using economic models to capture importance policy for tuning in autonomic database management systems', International Journal of Autonomic Computing, 2, pp. 114, http://dx.doi.org/10.1504/ijac.2016.082027
, 2016, 'Using economic models to capture importance policy for tuning in autonomic database management systems', International Journal of Autonomic Computing, 2, pp. 114, http://dx.doi.org/10.1504/ijac.2016.10002935
, 2015, 'The longitudinal reliability and responsiveness of the OMERACT Hand Osteoarthritis Magnetic Resonance Imaging Scoring System (HOAMRIS)', Journal of Rheumatology, 42, pp. 2486 - 2491, http://dx.doi.org/10.3899/jrheum.140983
, 2015, 'The OMERACT MRI in arthritis working group - Update on status and future research priorities', Journal of Rheumatology, 42, pp. 2470 - 2472, http://dx.doi.org/10.3899/jrheum.141248
, 2015, 'Validation of the OMERACT magnetic resonance imaging joint space narrowing score for the wrist in a multireader longitudinal trial', Journal of Rheumatology, 42, pp. 2480 - 2485, http://dx.doi.org/10.3899/jrheum.141009
, 2015, 'Validation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) for the hand and foot in a randomized placebo-controlled trial', Journal of Rheumatology, 42, pp. 2473 - 2479, http://dx.doi.org/10.3899/jrheum.141010
, 2015, 'Patients with rheumatoid arthritis in the Australian OPAL cohort show significant improvement in disease activity over 5 years: A multicenter observational study', Journal of Rheumatology, 42, pp. 1603 - 1609, http://dx.doi.org/10.3899/jrheum.141575
, 2015, 'Utility of in-office extremity magnetic resonance imaging in rheumatology', Indian Journal of Rheumatology, 10, pp. 140 - 146, http://dx.doi.org/10.1016/j.injr.2015.06.002
, 2015, 'Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): Study protocol for a randomized controlled trial', Trials, 16, http://dx.doi.org/10.1186/s13063-015-0671-8
, 2015, 'SAT0258 Baseline MRI/CRP as Predictors of Response to Etanercept in the Management of Patients with Non-Radiographic Axial Spondyloarthritis', Annals of the Rheumatic Diseases, 74, pp. 752, http://dx.doi.org/10.1136/annrheumdis-2015-eular.2254
, 2015, 'SAT0562 Long-Term (104-Week) Efficacy and Safety of Apremilast Monotherapy in Dmard-Naïve Patients with Psoriatic Arthritis: A Phase 3, Randomized, Controlled Trial and Open-Label Extension (Palace 4)', Annals of the Rheumatic Diseases, 74, pp. 863 - 864, http://dx.doi.org/10.1136/annrheumdis-2015-eular.2896
, 2015, 'SAT0585 Can we Stop Using Contrast in RA MRI Clinical Trials? Quantitative MRI Demonstrates Similar Responsiveness for Contrast and Contrast-Free Synovitis Assessment', Annals of the Rheumatic Diseases, 74, pp. 873, http://dx.doi.org/10.1136/annrheumdis-2015-eular.4884
, 2015, 'SAT0601 A Novel, Fully 3-Dimensional Dynamic Contrast MRI Method in the Hand Reveals Details of Synovial Inflammation and Provides a Sensitive Measure of Change', Annals of the Rheumatic Diseases, 74, pp. 879, http://dx.doi.org/10.1136/annrheumdis-2015-eular.6400
, 2015, 'Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial', The Lancet, 386, pp. 1137 - 1146, http://dx.doi.org/10.1016/s0140-6736(15)61134-5
, 2015, 'THU0146 Dispensing of Biologics Prescribed for the Treatment of Rheumatoid Arthritis in the Australian Population', Annals of the Rheumatic Diseases, 74, pp. 246 - 247, http://dx.doi.org/10.1136/annrheumdis-2015-eular.4326
, 2014, 'How well do patients understand written instructions?: Health literacy assessment in rural and urban rheumatology outpatients', Medicine United States, 93, http://dx.doi.org/10.1097/MD.0000000000000129
, 2014, 'No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: Results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial', Rheumatology United Kingdom, 53, pp. 746 - 756, http://dx.doi.org/10.1093/rheumatology/ket426